Letter to the editor
In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease. Response
Alessia Argirò a Jeffrey Ding b Eric Adler b
a
Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy
b
Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, California, United States
For the purchase of this article it is necessary to fill in the following form:
Customer service
Phone
Calls from Spain
932 415 960
Llamadas desde el extranjero
+34 932 415 960
Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm.
E-mail